Evidence map›Paper›PMID 29743094›Full record

ArticleCritical care (London, England)2018

Feasibility and safety of low-flow extracorporeal CO

Matthieu Schmidt, Samir Jaber, Elie Zogheib, Thomas Godet, Gilles Capellier, Alain Combes

3 registry-linked trialsAbstract read
In one paragraph

Article in Critical care (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02606240 completednot on this map

Extracorporeal CO2 Removal (ECCO2R) With a Renal Replacement Platform (PRISMALUNG) to Enhance Lung Protective Ventilation in Patients With Mild to Moderate Acute Respiratory Distress Syndrome (ARDS)

TypeobservationalSponsorGroupe Hospitalier Pitie-SalpetriereRan2016 to 2017Enrolled20ConditionsAcute Respiratory Distress SyndromeArmsCO2 removal with PRISMALUNG in ARDS
NCT04351906 nacompletednot on this mapstarted 2020, after this paper: background citation

Low-flow Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform for Correction of Hypercapnia in COVID-19-associated Acute Respiratory Distress Syndrome

TypeinterventionalSponsorUniversity of GiessenRan2020 to 2024Enrolled20ConditionsARDS, Hypercapnic Respiratory Failure, AKIArmsECCO2R
NCT06938217 naenrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Safety and Efficacy of Low-Flow ECMO in a Multi-modal Cohort of Adults in Respiratory Failure

TypeinterventionalSponsorInstitute for Extracorporeal Life SupportRan2025 to 2027Enrolled30ConditionsAcute Hypoxemic Respiratory Failure, Mechanical Ventilation, Acute Respiratory Distress Syndrome (ARDS)ArmsLow-flow ECMO
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Effects of extracorporeal COCritical care (London, England) · 2024
    Pooled it
  3. The evolution of ECCO₂R: rethinking pump selection.Critical care (London, England) · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Effect of low bicarbonate substitution solution on COIntensive care medicine experimental · 2025
    Article
  10. Review
  11. The role of extracorporeal COFrontiers in medicine · 2025
    Review
  12. Review
  13. Article
  14. Lung (extracorporeal COJournal of anesthesia, analgesia and critical care · 2024
    Article
  15. Article
  16. Low-flow ECCOHeliyon · 2024
    Article
  17. Article
  18. Current knowledge gaps in extracorporeal respiratory support.Intensive care medicine experimental · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthieu SchmidtSorbonne Université, INSERM, UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Pitié-Salpêtrière Hospital, F-75013, Paris, France.
Samir JaberDépartement d'Anesthésie et Réanimation B, CHU de Montpellier, Hôpital Saint-Eloi, INSERM Unité 1046, Université Montpellier 1, Montpellier, France.
Elie ZogheibAnesthesiology and Critical Care Medicine Department, Amiens University Hospital, INSERM U-1088, Université de Picardie Jules-Verne, 80054, Amiens Cedex, France.
Thomas GodetDépartement de Médecine Périopératoire (MPO), Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand, France.
Gilles CapellierMedical Intensive Care Unit, Besançon University Hospital, Besançon, France.
Alain CombesSorbonne Université, INSERM, UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Pitié-Salpêtrière Hospital, F-75013, Paris, France. alain.combes@aphp.fr.ORCID 0000-0002-6030-3957

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtracorporeal carbon-dioxide removal (ECCO

methodsTwenty patients with mild (n = 8) or moderate (n = 12) ARDS were included. VT was gradually lowered from 6 to 5, 4.5, and 4 ml/kg, and PEEP adjusted to reach 23 ≤ P

resultsWhile VT was reduced from 6 to 4 ml/kg and P

conclusionsA low-flow ECCO

trial registrationClinicalTrials.gov, NCT02606240. Registered on 17 November 2015.

Indexed as

AgedAged, 80 and overBlood Gas AnalysisCarbon DioxideExtracorporeal CirculationFemaleHumansIntensive Care UnitsMaleMiddle AgedPatient SafetyPilot ProjectsPositive-Pressure RespirationRespiration, ArtificialRespiratory Distress SyndromeTidal VolumeCarbon DioxideAcute respiratory distress syndromeExtracorporeal carbon-dioxide removalProtective ventilation

Identifiers

PMID29743094
PMCPMC5944133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.